Briacell Therapeutics Corp
BCTX8.950USD
-0.060-0.67%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
16.86MMarket Cap
LossP/E TTM
Briacell Therapeutics Corp Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-62.19
-1323.73%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Briacell Therapeutics Corp?
According to Briacell Therapeutics Corp's FY2025 earnings report, its total revenue reached --, with a year-on-year change of --.
What is the Earnings Per Share (EPS) of Briacell Therapeutics Corp?
According to Briacell Therapeutics Corp's FY2025 earnings report, its Earnings Per Share (EPS) was -62.186, with a year-on-year change of -1323.73%.
What is the net income of Briacell Therapeutics Corp?
According to Briacell Therapeutics Corp's FY2025 earnings report, its net income was -26.31M, with a year-on-year change of -449.14%.
What is the net margin of Briacell Therapeutics Corp?
According to Briacell Therapeutics Corp's FY2025 earnings report, its net profit margin was --, with a year-on-year change of --.
What is the gross margin of Briacell Therapeutics Corp?
According to Briacell Therapeutics Corp's FY2025 earnings report, its gross margin was --, with a year-on-year change of --.
What is the debt-to-asset ratio of Briacell Therapeutics Corp?
According to Briacell Therapeutics Corp's FY2025 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Briacell Therapeutics Corp?
According to Briacell Therapeutics Corp's FY2025 earnings report, its Return on Equity (ROE) was -339.54%, with a year-on-year change of --.
What is the Return on Assets (ROA) of Briacell Therapeutics Corp?
According to Briacell Therapeutics Corp's FY2025 earnings report, its Return on Assets (ROA) was -192.98%, with a year-on-year change of -546.38%.
What is the operating profit of Briacell Therapeutics Corp?
According to Briacell Therapeutics Corp's FY2025 earnings report, its operating profit was -27.20M, with a year-on-year change of 18.38%.
What are the current assets of Briacell Therapeutics Corp?
According to Briacell Therapeutics Corp's FY2025 earnings report, its current assets were 19.93M, with a year-on-year change of 445.36%.
What are the total assets of Briacell Therapeutics Corp?
According to Briacell Therapeutics Corp's FY2025 earnings report, its total assets of Briacell Therapeutics Corp were 21.65M, with a year-on-year change of 268.68%.
What are the total liabilities of Briacell Therapeutics Corp?
According to Briacell Therapeutics Corp's FY2025 earnings report, its total liabilities of Briacell Therapeutics Corp were 4.32M, with a year-on-year change of -49.57%.
What is the total equity of Briacell Therapeutics Corp?
According to Briacell Therapeutics Corp's FY2025 earnings report, its total equity of Briacell Therapeutics Corp was 17.33M, with a year-on-year change of 745.60%.
What is the net operating income of Briacell Therapeutics Corp?
According to Briacell Therapeutics Corp's FY2025 earnings report, its net operating income of Briacell Therapeutics Corp was -26.56M, with a year-on-year change of -438.50%.
What is the net investment of Briacell Therapeutics Corp?
According to Briacell Therapeutics Corp's FY2025 earnings report, its net investment of Briacell Therapeutics Corp was -7.65M, with a year-on-year change of -1021.44%.
What is the net financing of Briacell Therapeutics Corp?
According to Briacell Therapeutics Corp's FY2025 earnings report, its net financing of Briacell Therapeutics Corp was 45.45M, with a year-on-year change of 928.49%.
